{
    "code": "02024565",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024565",
    "time": "2021-10-08 06:47:54",
    "許可證字號": "衛署藥輸字第024565號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/14",
    "發證日期": "95\/11\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202456508",
    "中文品名": "救必辛注射劑",
    "英文品名": "Cubicin Injection",
    "適應症": "1. 治療成人及兒童（1至17歲）病人因下列感受性革蘭氏陽性菌引起的複雜性皮膚和皮膚組織感染 (cSSSI)：Staphylococcus aureus（包括methicillin-resistant isolates）、Streptococcus pyogenes、Streptococcus agalactiae、Streptococcus dysgalactiae subsp. equisimilis與Enterococcus faecalis (vancomycin-susceptible isolates only)。\r\n2. 治療成人病人因Staphylococcus aureus引起之血液感染（菌血症），包括由具methicillin感受性及抗藥性菌株造成之右側感染性心內膜炎。\r\n3. 治療兒童（1至17歲）病人因Staphylococcus aureus引起之血液感染（菌血症）。",
    "劑型": "243凍晶注射劑",
    "包裝": "500mg玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DAPTOMYCIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1406801100  臺灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6111021077  臺灣東洋藥品工業股份有限公司六堵廠",
            "製造廠廠址": "基隆市七堵區工建西路5號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FCH0314000  Cubist Pharmaceuticals, LLC",
            "製造廠廠址": "Weystrasse 20, 6000 Lucerne 6, Switzerland",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812002700",
            "成分名稱": "DAPTOMYCIN",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡黃色至淡棕色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020245650004 藥物外觀-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024565&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cubicin_仿單完稿_20191203-108-12-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024565&Seq=002&Type=9"
        },
        {
            "title": "020245650003 外盒(A03)_20161108_國外許可證持有者名稱及地址變更-106-03-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024565&Seq=008&Type=8"
        },
        {
            "title": "020245650002 瓶標(A02)_20161108_國外許可證持有者名稱及地址變更-106-03-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024565&Seq=007&Type=8"
        }
    ]
}